Limor Cohen

920 total citations
35 papers, 678 citations indexed

About

Limor Cohen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Limor Cohen has authored 35 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Limor Cohen's work include Cystic Fibrosis Research Advances (5 papers), Trace Elements in Health (4 papers) and Muscle Physiology and Disorders (3 papers). Limor Cohen is often cited by papers focused on Cystic Fibrosis Research Advances (5 papers), Trace Elements in Health (4 papers) and Muscle Physiology and Disorders (3 papers). Limor Cohen collaborates with scholars based in Israel, United States and Germany. Limor Cohen's co-authors include Israel Sekler, Michal Hershfinkel, Moshe Elkabets, Manu Prasad, Jonathan Zorea, Ksenia M. Yegodayev, Ben‐Zion Joshua, Barak Rotblat, Ari Bergwerk and Eitan Kerem and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Limor Cohen

31 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Limor Cohen Israel 15 267 189 184 121 105 35 678
Xiaoxi Chen China 15 269 1.0× 225 1.2× 184 1.0× 41 0.3× 75 0.7× 48 784
Grzegorz Woszczek Poland 20 214 0.8× 109 0.6× 56 0.3× 42 0.3× 260 2.5× 39 834
Motonari Nomura Japan 14 368 1.4× 187 1.0× 152 0.8× 31 0.3× 118 1.1× 56 819
Simona Laurino Italy 14 198 0.7× 268 1.4× 68 0.4× 43 0.4× 64 0.6× 34 707
Margit Dlaska Austria 11 232 0.9× 55 0.3× 84 0.5× 55 0.5× 122 1.2× 16 543
Nobuya Ohishi Japan 19 487 1.8× 182 1.0× 131 0.7× 43 0.4× 86 0.8× 48 964
Eric D. Strauch United States 18 494 1.9× 123 0.7× 190 1.0× 65 0.5× 111 1.1× 38 1.0k
Patricia G. Phillips United States 20 346 1.3× 123 0.7× 80 0.4× 46 0.4× 168 1.6× 40 952
Marianna Agassandian United States 12 209 0.8× 191 1.0× 85 0.5× 31 0.3× 60 0.6× 14 538
Alexandra Evagelidis Canada 13 328 1.2× 363 1.9× 55 0.3× 40 0.3× 45 0.4× 20 673

Countries citing papers authored by Limor Cohen

Since Specialization
Citations

This map shows the geographic impact of Limor Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limor Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limor Cohen more than expected).

Fields of papers citing papers by Limor Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limor Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limor Cohen. The network helps show where Limor Cohen may publish in the future.

Co-authorship network of co-authors of Limor Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Limor Cohen. A scholar is included among the top collaborators of Limor Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limor Cohen. Limor Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Limor, Riki Goldbart, Tamar Traitel, et al.. (2025). Targeted siRNA Delivery Using Cetuximab‐Conjugated Starch for Epidermal Growth Factor Receptor‐Driven Head and Neck Squamous Cell Carcinoma. Small Science. 5(7). 2500073–2500073.
2.
Cohen, Limor, Yael Lavi, Riki Goldbart, et al.. (2024). Elucidating siRNA Cellular Delivery Mechanism Mediated by Quaternized Starch Nanoparticles. Small. 20(51). e2405524–e2405524. 4 indexed citations
3.
Peng, Xin, Xin Huang, Wenqing Jia, et al.. (2024). A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation. Molecular Cancer. 23(1). 54–54. 22 indexed citations
4.
Mullins, Mark E., Limor Cohen, Patrick A. Flume, et al.. (2023). 14 Spontaneous changes to airway microbiology after initiation of elexacaftor-tezacaftor-ivacaftor in people with advanced cystic fibrosis lung disease. Journal of Cystic Fibrosis. 22. S9–S9. 1 indexed citations
5.
Flume, Patrick A., et al.. (2021). Short-term effect of elexacaftor-tezacaftor-ivacaftor on lung function and transplant planning in cystic fibrosis patients with advanced lung disease. Journal of Cystic Fibrosis. 20(5). 768–771. 29 indexed citations
6.
Yegodayev, Ksenia M., Ofra Novoplansky, Manu Prasad, et al.. (2020). TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer. Cancers. 12(2). 339–339. 47 indexed citations
7.
Ghosh, Susmita, Manu Prasad, Kiran Kundu, et al.. (2019). Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy. Frontiers in Oncology. 9. 17–17. 19 indexed citations
8.
Prasad, Manu, Jonathan Zorea, Ksenia M. Yegodayev, et al.. (2019). Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy. JCI Insight. 4(8). 45 indexed citations
9.
Zorea, Jonathan, Manu Prasad, Limor Cohen, et al.. (2018). IGF1R upregulation confers resistance to isoform-specific inhibitors of PI3K in PIK3CA-driven ovarian cancer. Cell Death and Disease. 9(10). 944–944. 37 indexed citations
10.
Sunuwar, Laxmi, et al.. (2016). The zinc sensing receptor, ZnR/GPR39, triggers metabotropic calcium signalling in colonocytes and regulates occludin recovery in experimental colitis. Philosophical Transactions of the Royal Society B Biological Sciences. 371(1700). 20150420–20150420. 41 indexed citations
11.
Cohen, Limor, George R. Bousfield, & David Ben-Menahem. (2015). The recombinant equine LHβ subunit combines divergent intracellular traits of human LHβ and CGβ subunits. Theriogenology. 83(9). 1469–1476. 3 indexed citations
12.
Cohen, Limor, Israel Sekler, & Michal Hershfinkel. (2014). The zinc sensing receptor, ZnR/GPR39, controls proliferation and differentiation of colonocytes and thereby tight junction formation in the colon. Cell Death and Disease. 5(6). e1307–e1307. 78 indexed citations
13.
Brusilovsky, Michael, Limor Cohen, Rami Yossef, et al.. (2014). Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in ‐cis: A lesson from NKp44. European Journal of Immunology. 45(4). 1180–1191. 30 indexed citations
14.
15.
Werlin, Steven L., Limor Cohen, Eitan Kerem, et al.. (2008). Enteropathy – a new finding in cystic fibrosis. Journal of Cystic Fibrosis. 7. S79–S79. 1 indexed citations
16.
Shoham, Nitza G., Limor Cohen, A. Yaniv, & Arnona Gazit. (2003). The Tat protein of the human immunodeficiency virus type 1 (HIV-1) interacts with the EGF-like repeats of the Notch proteins and the EGF precursor. Virus Research. 98(1). 57–61. 16 indexed citations
17.
Hiscott, John, Anne Roulston, Mario D’Addario, Jérôme Lacoste, & Limor Cohen. (1992). La régulation de l'expression de VIH-1 et l'activation des gènes de cytokines. médecine/sciences. 8(4). 346–346.
18.
Cohen, Limor, James P. Morgan, R.K. Babbs, et al.. (1982). A statistical analysis of the loss of muscle strength in Duchenne's muscular dystrophy.. PubMed. 37(1). 123–38. 5 indexed citations
19.
Cohen, Limor, et al.. (1977). Effects of the simultaneous administration of diethylstilbestrol and prednisolone on serum enzymes in Duchenne's muscular dystrophy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 8(2). 123–34. 3 indexed citations
20.
Cohen, Limor. (1967). Contributions of serum enzymes and isozymes to the diagnosis of myocardial injury. 2.. PubMed. 36(9). 49–54. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoxi Chen Breakdown of academic impact, for papers by Grzegorz Woszczek Breakdown of academic impact, for papers by Motonari Nomura Breakdown of academic impact, for papers by Simona Laurino Breakdown of academic impact, for papers by Margit Dlaska Breakdown of academic impact, for papers by Nobuya Ohishi Breakdown of academic impact, for papers by Eric D. Strauch Breakdown of academic impact, for papers by Patricia G. Phillips Breakdown of academic impact, for papers by Marianna Agassandian Breakdown of academic impact, for papers by Alexandra Evagelidis
Rankless by CCL
2026